Evidence for an autologous immune complex pathogenic mechanism in acute poststreptococcal glomerulonephritis. Clinical and experimental studies have suggested a role for antiimmunoglobulins in the pathogenesis of glomerulonephritis associated with streptococcal infection. We attempted to localize anti-IgG in the kidneys of 22 patients who had renal biopsies performed 7 to 66 days after the onset of acute poststreptococcal glomerulonephritis (APSGN). In addition to routine localization of immunoglobulins and C3, specimens were stained with neuraminidasetreated, heat-aggregated, and unmodified IgG. Twelve biopsies showed staining with fluorescein-labeled human neuraminidasetreated IgG. A lesser number gave positive staining with the other IgG preparations. Following treatment of slides with 0.01 M citrate buffer, seven previously negative biopsies showed positive staining with neuraminidase-treated IgG. The demonstration of anti-IgG by these methods was possible in 19 out of 22 biopsies. It correlated best with the presence of C3 and IgG, and to a lesser extent with 1gM, in the renal glomerulus. These resuits and our previous finding of elevated levels of serum antiIgG early in the course of APSGN, and as early as 8 days following the antecedent streptococcal infection, support a role for anti-IgG in the immune pathogenesis of APSGN. Although our series of studies support the hypothesis that anti-IgG is formed to an IgG modified enzymatically by streptococcal product, the formation of this autoantibody to IgG incorporated in an exogenous (streptococcal antigen-antibody) complex can not be ruled out.
experimental studies have suggested a role for antiimmunoglobulins in the pathogenesis of glomerulonephritis associated with streptococcal infection. We attempted to localize anti-IgG in the kidneys of 22 patients who had renal biopsies performed 7 to 66 days after the onset of acute poststreptococcal glomerulonephritis (APSGN). In addition to routine localization of immunoglobulins and C3, specimens were stained with neuraminidasetreated, heat-aggregated, and unmodified IgG. Twelve biopsies showed staining with fluorescein-labeled human neuraminidasetreated IgG. A lesser number gave positive staining with the other IgG preparations. Following treatment of slides with 0.01 M citrate buffer, seven previously negative biopsies showed positive staining with neuraminidase-treated IgG. The demonstration of anti-IgG by these methods was possible in 19 out of 22 biopsies. It correlated best with the presence of C3 and IgG, and to a lesser extent with 1gM, in the renal glomerulus. These resuits and our previous finding of elevated levels of serum antiIgG early in the course of APSGN, and as early as 8 days following the antecedent streptococcal infection, support a role for anti-IgG in the immune pathogenesis of APSGN. Although our series of studies support the hypothesis that anti-IgG is formed to an IgG modified enzymatically by streptococcal product, the formation of this autoantibody to IgG incorporated in an exogenous (streptococcal antigen-antibody) complex can not be ruled out. The finding of cryoglobulins in the sera of these patients, and particularly, the demonstration of sialic acid depletion of the IgG component of these cryoproteins, led to the postulation that such alteration in the structure could account for an antigenic transformation of autologous IgG [5] [6] [7] . Demonstration in rabbits of the nephritogenic potential of autolgous IgG thus modified by streptococcus and, more specifically, by neuraminidase, suggested a possible determinant role for this material in the pathogenesis of acute poststreptococcal glomerulonephritis (APSGN) [8, 9] : antiglobulin response to altered IgG could result in the formation of circulating or glomerular-fixed immune complexes.
Recently, we have demonstrated anti-IgG in the serum of the majority of the patients with APSGN, and found that these autoantibodies appear very early in the course of the disease [10- (aggregated by heat and precipitation with sodium sulfate). CIqBA was measured in over 100 apparently healthy subjects. The mean binding obtained was 9 .5 2.6. Therefore, the mean + 2 SD was 14.7, and in our laboratories Clq greater than 15% is considered abnormal. Rheumatoid factor was determined by agglutination using latex particles coated with IgG and by immunoabsorbent using IgG coupled to CNBR activated sepharose [10, 11] .
The serologic studies were performed on 119 patients admitted to the hospital with well-documented APSGN [10, 11] . The 22 patients reported here were selected from the total group and represent those patients from whom renal tissue was available for study.
Renal biopsy studies. A portion of the renal biopsy specimen was fixed in 10% buffered formalin and 4-paraffin sections stained with hematoxylin and eosin (H&E) and periodic acid Schiff reagent (PAS) for light microscopy. A part of the tissue was fixed in gluteraldehyde for electron microscopy. The remainder of the specimen was snap-frozen in dry ice and acetone and stored at -70° C for immunohistologic studies. Immunofluorescent studies were performed on 4-es cryostat sections with fiuorescein isothyocyanate (FITC)-conjugated rabbit antisera to human IgG (RAH IgG), 1gM (RAH 1gM), and C3 (RAH C3). In addition, unmodified human IgG (HIgG-u) aggregated human IgG (HIgGagg) and neuraminidase-treated (sialic-acid-depleted) human IgG (HIgG-N) were conjugated with FITC and used to stain the frozen section by conventional direct immunofluorescent staining methodology. FITC-conjugated unmodified rabbit IgG (RIgG-u) and FITC rabbit aggregated (RIgG-agg) were also used for staining purposes. In all specimens in which fluorescent deposits of IgG preparations were not observed, the sections were treated with 0.01 M citrate buffer (pH, 3.2) for 1, 4, and 12 hr at 26° C. The immunofluorescent staining was then repeated. Renal biopsy specimens from 97 patients with a variety of renal diseases (see Table 5 ) were studied by the same immunohistologic methods using the identical antisera.
The methodology used for immunohistologic observations has been described previously [13] [14] [15] [16] .
Preparation of human IgG reagents (HIgG). Immunoglobulin G (IgG) was isolated from the serum. of healthy United States males by precipitation with ammonium sulfate, ion exchange chromatography on diethylaminoethyl cellulose (DEAE), and Sephadex G-200 gel filtration chromatography. The serum donors had no history of recent illness, no antibodies to streptococcal enzymes (streptolysin 0, hyaluronidase, streptozyme), and they had normal urine analyses and endogenous creatinine clearances. Donors' serum levels of C3 and immunoglobulins (G, M, and A) were normal, and no Clq binding activity was detected in the serum. Rheumatoid factor was not detected in their sera.
The IgG preparation was characterized by immu-noelectrophoresis, Ouchterlony double diffusion in agar gel, and cellulose acetate electrophoresis. No other serum proteins were detected in the material.
Part of the IgG solution was conjugated with FITC, and a final concentration of 20 mg/ml was used for immunohistochemical studies. Part of the IgG was treated with neuraminidase as described previously [9] and neuraminidase-treated IgG (HIgG-N) purified by ammonium sulfate precipitation and gel chromatography using Sephadex G 200 [9] . No neuraminidase was detected in the preparation. The HIgG-N was conjugated with FITC, and a concentration of 20 mglml was used for immunofluorescent studies. Immuoglobulin U was aggregated by heating at 63° C for 20 mm followed by precipitation with sodium sulfate. The aggregated IgG was separated by chromatography on Sephadex G-200 and Sepharose 6B. Only the fraction in the exclusion volume of Sephadex G-200 was used. This fraction appeared as a single peak on Sepharose. The IgG was conjugated with FITC, and a concentration of 20 mg/mI of the material (HIgG-agg) was used for fluorescent studies.
Preparation of rabbit IgG reagents (RJgG). Fluorescein-conjugated unmodified rabbit IgG (RIgG-u) and fluorescein-conjugated rabbit aggregated IgG (RIgG-agg) were prepared in a manner similar to that described for the human IgG counterparts. No antibodies to human serum proteins or streptococcal enzymes were detected in the rabbit serum.
Results
The serologic data on the 119 patients from whom the cases in this study were selected are the subject of separate communications [10, 11, 17] and are summarized in Table 1 . All 22 patients in the study had markedly elevated levels of serum IgG and 1gM.
Serum IgA levels were elevated in six patients. The C3 levels were depressed in all patients, and Clq binding activity was elevated in 10 cases. Rheumatoid factor titers were elevated in all patients ( a C3, rheumatoid factor (RF), Clq binding (CIqBA), antistreptolysin 0 (ASO), antihyaluronidase (AH), and streptozyme (SZ), were performed at the time of admission to the hospital. Site of infection is: S. skin; T, throat. Days from onset of infection by history and onset of clinical signs of nephritis represent the interval between these times and obtaining serological data. U is unknown. tions suggestive of chronicity were observed. The results of immunohistologic studies are shown in Table 3 . The interval of time that elapsed from the biopsy to the first sign or symptom of infection and nephritis is also noted in Table 3 Of those biopsies that presented positive staining with HIgG-N, seven were also positive with RIgG-u. In general, staining with HIgG-N was the most prominent, staining with HIgG-u was somewhat less, and the staining with HIgG-agg was more commonly focal, segmental, and weaker. Figs. 1-6 shows immunohistologic staining of representative glomeruli from patient #171.
Following treatment of the negative biopsy specimens with citrate buffer, 1gM and IgG were not localized in those patients in whom these immunoglobulins were not detected by direct immunofluorescence prior to elution. However, After a 12-hr elution period, it was possible to show HIgG-N fixed in the glomeruli of seven out of nine patients that were previously negative. The same was true for six out of nine patients with respect to HIgG-u.
The results of the acid elution experiments are shown in Table 4 . A variety of immunohistologic patterns were observed: fine granular capillary walls, fine or coarse, granular, mesangial, or combinations. In general, deposits with all fluorescent reagents showed similar patterns in the same patient. The results of immunohistologic studies on controls are shown in Table 5 . The nature of the association between streptococcal infection and nephritis led to early speculation that an exogenous antigen, related to streptococcus, was involved in the formation of pathogenic immune complexes. Several investigators, however, have attempted to localize soluble streptococcal antigens in the glomeruli of patients with APSGN, but the results have been negative, difficult to repeat, or inconclusive [1, [18] [19] [20] . Treser et al have detected streptococcal antigenic material, distinct from M protein, in the glomeruli of early biopsy tissue from patients with APSGN [19, 20] . These investigators stress the importance of the We have reported the detection of serum cryoglobulins with biologic properties of immune complexes in all patients studied during the acute phase of APSGN [7] . Streptococcal immunoreactive material could only occasionally be found as a constituent of these cryoproteins by a variety of immunological techniques [5] [6] [7] . Moreover, streptococcal antigen and antibody were never detected simultaneously in cryoprecipitates isolated from patients with this disease [5] [6] [7] . The finding of anti-IgG activity in some of the cryoprecipitates led to the suggestion of a role for an autologous immune-complex mechanism in nephritis related to streptococcal infection [6] . In this postulated mechanism, antibodies produced to IgG rendered autoimmunogenic by interaction with or modification by a streptococcal product or by incorporation into immune complexes, led to the formation of (anti-IgG) (IgG) pathogenic immune complexes. These autoantibodies could react with the neoantigen in the circulation in situ in the renal glomerulus. In addition, the autoantibody may also partially react with native host IgG.
In a previous communication, we have reported the isolation of an 1gM anti-IgG cryoprotein in which the IgG fraction lacked sialic acid [6] . Zinneman, Levi, and Seal isolated a similar cryoglobulin from a patient with essential cryoglobulinemia and showed that the 1gM fraction reacted with neuraminidase-treated (sialic-acid-depleted) IgG, whereas only a very weak reaction was observed with unmodified IgG [24] . We have shown that the sialic acid content of IgG was markedly decreased by incubation with a culture of nephritogenic streptococcus [25] . Autologous IgG modified either by incubation with this microorganism or by treatment with neuraminidase was capable of inducing cryoglobulinemia, anti-IgG antibodies, and glomerulonephritis characterized by granular deposition of IgG and C3 [8, 9] . These events occurred in the absence of streptococcal infection, elevation of antistreptolysin 0 titer, or deposits of streptococcal material in the glomerulus. Other investigators have demonstrated the production of monoclonal cryoglobulins with anti-IgG activity in rabbits following immunization with streptococcal vaccines [261. Preliminary studies by Davis, Baig, and Ayoub have shown that certain strains of streptococcus produce neuraminidase [27] . We have observed elevated titers of anti-IgG activity as early as 10 days following the onset of streptococcal infection and on the day of onset of symptoms of nephritis in patients with APSGN [10, 11] . These studies suggest that the production of antiglobulins in APSGN may be related to the streptococcal infection and may be a primary event in APSGN. It is possible, however, that the antiIgG is an antibody to IgG incorporated in an exogenous immune complex of streptococcal-related antigen and specific antibody. The fixation of neuraminidase-treated IgG to the glomerulus of patients in this study supports an au- tologous immune mechanism in this disease. Reactivity was also observed with unmodified IgG and aggregated IgG; the fluorescence with these latter reagents, however, was much less prominent. In previous studies, we have shown partial immunologic cross-reactivity between unmodified IgG and neuraminidase-treated IgG [9] .
Elution studies permitted the demonstration of anti-IgG activity in previously negative biopsies. These studies suggest that, in some patients, complete saturation of antigen with antibody is taking place.
The hypothesis that antiglobulins are produced in response to a neoautoimmunogen resulting from the action of a streptococcal neuraminidase-like enzyme, is not unattractive. Anti-IgG antibodies have been found in the glomeruli of some patients with nephritis, and it has been suggested that their presence can exacerbate immune-complex renal disease [281. In addition, immunoglobulin complexes (IgG1gM, IgG-IgG) have been implicated in the pathogenesis of the renal lesion in systemic lupus erythematosus [29] , progressive systemic sclerosis [301, and essential cryoglobulinemia [32] . It is of interest that ultrastructural studies of glomeruli of some patients with IgM-anti-IgG cryoglobulinemia have revealed subepithelial "humps" indistinguishable from those observed in APSGN [311.
In our laboratories, we have looked routinely for antiglobulins in renal biopsy specimens. Excluding a few cases of the nephritis of systemic lupus erythematosus, we have failed to detect these autoantibodies.
It is quite possible that the immune injury in APSGN involves a variety of exogenous and endog- 
